Results 161 to 170 of about 26,322 (190)

Reducing the risk of anaphylaxis during anaesthesia: Guidelines for clinical practice [PDF]

open access: yes, 2005
Aberer, W.   +58 more
core  

Cisatracurium or rocuronium versus rocuronium-cisatracurium combination.

Middle East journal of anaesthesiology, 2007
The present report evaluates the incidence of pain on intravenous injection and the condition of tracheal intubation at one minute following the administration of cisatracurium or rocuronium versus rocuronium-cisatracurium combination. We studied 60 patients, ASA 1, aged 18-60 years, undergoing elective surgical procedures.
Ahed, Zeidan   +3 more
openaire   +1 more source

[Rocuronium].

Revista espanola de anestesiologia y reanimacion, 1998
Rocuronium is a new nondepolarizing neuromuscular blocking agent (NDNMBA) that has recently been introduced for clinical use. Its main advantage over other such agents is its rapid onset of action, which may lead to its use as the relaxant of choice when rapid intubation is required. An additional advantage is that, unlike other amino-steroidal NDNMBAs,
openaire   +1 more source

Intramuscular Rocuronium

Anesthesiology, 1997
P, Szmuk, A, Radulescu, T, Ezri, D, Geva
openaire   +2 more sources

Home - About - Disclaimer - Privacy